Form 8-K - Current report:
SEC Accession No. 0001437749-24-029198
Filing Date
2024-09-16
Accepted
2024-09-16 08:15:29
Documents
42
Period of Report
2024-09-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20240913_8k.htm   iXBRL 8-K 26552
2 EXHIBIT 99.1 ex_723789.htm EX-99.1 16709
7 moleculinnewlogoresized.jpg GRAPHIC 7783
8 slide01.jpg GRAPHIC 67850
9 slide02.jpg GRAPHIC 94557
10 slide03.jpg GRAPHIC 49782
11 slide04.jpg GRAPHIC 64143
12 slide05.jpg GRAPHIC 64494
13 slide06.jpg GRAPHIC 72390
14 slide07.jpg GRAPHIC 64579
15 slide08.jpg GRAPHIC 70424
16 slide09.jpg GRAPHIC 71165
17 slide10.jpg GRAPHIC 58794
18 slide11.jpg GRAPHIC 42826
19 slide12.jpg GRAPHIC 55163
20 slide13.jpg GRAPHIC 53617
21 slide14.jpg GRAPHIC 68812
22 slide15.jpg GRAPHIC 59296
23 slide16.jpg GRAPHIC 63585
24 slide17.jpg GRAPHIC 60419
25 slide18.jpg GRAPHIC 57463
26 slide19.jpg GRAPHIC 46576
27 slide20.jpg GRAPHIC 54071
28 slide21.jpg GRAPHIC 42836
29 slide22.jpg GRAPHIC 31628
30 slide23.jpg GRAPHIC 66359
31 slide24.jpg GRAPHIC 75879
32 slide25.jpg GRAPHIC 39997
33 slide26.jpg GRAPHIC 38300
  Complete submission text file 0001437749-24-029198.txt   2317347

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240916.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240916_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240916_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240916_pre.xml EX-101.PRE 12022
44 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240913_8k_htm.xml XML 2933
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 241299395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)